Pharvaris N.V.
PHVS
$32.94
$1.695.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 0.62% | 11.11% | 29.29% | 42.29% | 50.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.92% | 33.16% | 43.36% | 51.50% | 50.23% |
| Operating Income | -21.92% | -33.16% | -43.36% | -51.50% | -50.23% |
| Income Before Tax | -36.67% | -26.12% | -48.49% | -42.08% | -32.85% |
| Income Tax Expenses | 16.03% | 14.81% | 57.26% | 43.03% | 73.14% |
| Earnings from Continuing Operations | -36.39% | -26.01% | -48.59% | -42.09% | -33.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.39% | -26.01% | -48.59% | -42.09% | -33.27% |
| EBIT | -21.92% | -33.16% | -43.36% | -51.50% | -50.23% |
| EBITDA | -21.97% | -33.22% | -43.48% | -51.63% | -50.33% |
| EPS Basic | -25.37% | -14.73% | -30.34% | -12.58% | 5.06% |
| Normalized Basic EPS | -25.71% | -14.86% | -30.30% | -12.51% | 5.45% |
| EPS Diluted | -25.37% | -14.73% | -30.34% | -12.58% | 5.06% |
| Normalized Diluted EPS | -25.71% | -14.86% | -30.30% | -12.51% | 5.45% |
| Average Basic Shares Outstanding | 9.47% | 9.61% | 12.85% | 25.03% | 40.78% |
| Average Diluted Shares Outstanding | 9.47% | 9.61% | 12.85% | 25.03% | 40.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |